{
    "2020-03-20": [
        [
            {
                "time": "",
                "original_text": "沃森生物(300142.SZ)：募投项目“玉溪沃森疫苗产业园三期工程项目”等2个项目的延期 项目问题",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "募投项目",
                        "玉溪沃森疫苗产业园",
                        "三期工程",
                        "延期"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物(300142.SZ)拟设立昆明沃森实施募投项目",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "昆明沃森",
                        "募投项目",
                        "设立"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：预计一季度净亏损1800万元-2300万元，同比盈转亏 预亏",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "一季度",
                        "净亏损",
                        "盈转亏"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物(300142.SZ)：2019年度净利下降86.43%至1.42亿元 盈利能力下降",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "2019年度",
                        "净利下降",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物(300142.SZ)一季度预亏1800万–2300万元 同比盈转亏 预亏",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "一季度",
                        "预亏",
                        "盈转亏"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：2019年净利润同比减少86.43% 盈利能力下降",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "2019年",
                        "净利润",
                        "同比减少",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "分析疫情之下我国疫苗行业发展现状及趋势",
                "features": {
                    "keywords": [
                        "疫情",
                        "疫苗行业",
                        "发展现状",
                        "趋势"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}